EXC vs GMED · P/E 17, rev $24.26B vs P/E 42, rev $1.55B
Exelon Corporation (EXC) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the EXC and GMED stock pages for the full models.
Not investment advice.